Beam Therapeutics Inc. Net Income

Net Income of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income growth rates and interactive chart. Net income (NI), also called net earnings, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses. It is the profit available to all shareholders, both preferred and common.


Highlights and Quick Summary

  • Net Income for the quarter ending September 30, 2022 was $-110 Million (a 52.29% increase compared to previous quarter)
  • Year-over-year quarterly Net Income increased by 69.34%
  • Annual Net Income for 2021 was $-371 Million (a 90.47% increase from previous year)
  • Annual Net Income for 2020 was $-195 Million (a 148.44% increase from previous year)
  • Annual Net Income for 2019 was $-78.3 Million (a -32.9% decrease from previous year)
  • Twelve month Net Income ending September 30, 2022 was $-315 Million (a 34.81% increase compared to previous quarter)
  • Twelve month trailing Net Income decreased by -14.89% year-over-year
Trailing Net Income for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-315 Million $-234 Million $-238 Million $-371 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income of Beam Therapeutics Inc.

Most recent Net Incomeof BEAM including historical data for past 10 years.

Interactive Chart of Net Income of Beam Therapeutics Inc.

Beam Therapeutics Inc. Net Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-109.58 $-71.95 $-69.21
2021 $-64.71 $-28.12 $-76.25 $-201.56 $-370.64
2020 $-95.46 $-34.45 $-34.22 $-30.46 $-194.59
2019 $-27.85 $-19.01 $-17.86 $-13.61 $-78.33
2018 $-116.74 $-116.74
2017 $-8.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology